Net Cash Provided by (Used in) Financing Activities in USD of Q32 Bio Inc. from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Q32 Bio Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2017 to 2024.
  • Q32 Bio Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $99.3M, a 662207% increase year-over-year.
  • Q32 Bio Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $95.1M, a 23333% increase from 2023.
  • Q32 Bio Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $406K, a 31.9% decline from 2022.
  • Q32 Bio Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $596K, a 98.9% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Q32 Bio Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $99.3M +$99.3M +662207% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q1 2023 $15K -$425K -96.6% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q1 2022 $440K -$1.6M -78.5% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q1 2021 $2.04M +$1.6M +357% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q1 2020 $447K +$122K +37.5% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q1 2019 $325K +$1.28M 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q1 2018 -$958K 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019

Q32 Bio Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $95.1M +$94.7M +23333% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025
2023 $406K -$190K -31.9% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025
2022 $596K -$51.6M -98.9% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024
2021 $52.2M -$924K -1.74% 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023
2020 $53.1M -$105M -66.4% 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2022
2019 $158M +$7.22M +4.78% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2021
2018 $151M +$35.8M +31% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2020
2017 $115M 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.